Pricing Log in Create free account
Friday 6 November 2026 Export UFPT’s income statement to Excel — free account

UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.

Revenue
+11.6%
EPS
+25.6%
Free cash flow
−35.8%
Total debt
−40.2%

Quarter to September 2026, against a year earlier

301.79 1.97 +0.66%
Market cap
$2.3B
P/E
30.1×
Fwd P/E
29.2×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

UFP Technologies, Inc. (UFPT) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a EV/Sales of 3.7×. Over the past ten years it has ranged from 0.8× (July 2015) to 6.7× (September 2024); the current reading is higher than 88% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.1× (25.38%)
FY2024 4.1× 26.74%
FY2023 3.2× 23.47%
FY2022 2.6× (10.06%)
FY2021 2.9× 60.02%
FY2020 1.8× (2.00%)
FY2019 1.9× 45.49%
FY2018 1.3× 16.34%
FY2017 1.1× 3.41%
FY2016 1.1× 4.09%

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.7× 6.19%
Jun 2026 3.4× 28.93%
Mar 2026 2.7× (12.51%)
Dec 2025 3.1× 8.53%
43 more quarters

Against its own ten years

Low 0.8× High 6.7×
Ten-year median 1.8×
Current reading's percentile 87

EV/Sales against peers

Company EV/Sales
NVCR NovoCure Limited compare 1.8×
INSP Inspire Medical Systems, Inc. compare 1.8×
NEOG Neogen Corporation compare 3.6×
UFPT UFP Technologies, Inc. 3.7×
TMDX TransMedics Group, Inc. compare 3.8×
ESTA Establishment Labs Holdings Inc. compare 8.7×
AXGN AxoGen, Inc. compare 8.8×
BFLY Butterfly Network, Inc. compare 12.5×
ALMR Alamar Biosciences, Inc. compare 15.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on UFPT